Practice question

Answer the question and get instant feedback.

MediumEndocrinologyType 2 diabetes (add-on therapy)ukmlamrcgp aktpaneprescribing safety assessment

A 65-year-old woman with type 2 diabetes on metformin 1 g twice daily and lifestyle measures has persistent HbA1c 67 mmol/mol despite adherence. BMI 31 kg/m², eGFR 75 mL/min/1.73 m², no ASCVD. According to UK guidance, which addition is most appropriate to improve glycaemic control and support weight reduction?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.